Theriva Biologics Inc (TOVX) Stock Price, Quote & News

Company Profile

Theriva Biologics, Inc., a clinical-stage company, develops therapeutics to treat cancer and related diseases in areas of high unmet need in the United States. Its lead product candidate, VCN-01 (zabilugene almadenorepvec), a clinical stage oncolytic human adenovirus that is in Phase 1 clinical trials and Phase 2 VIRAGE trial for patients with pancreatic cancer, head and neck squamous cell carcinoma, ovarian cancer, colorectal cancer, and retinoblastoma. The company also develops VCN-11 for trea...

Industry: Biotechnology

Sector: Healthcare

Phone: 301 417 4364

Website: therivabio.com

Address:

9605 Medical Center Drive, Suite 270, Rockville, United States

ShangVXO Aug. 24 at 8:35 AM

Been tapped into @_ProfessorGamma for a minute now. The way they spot some of these plays before they run is nuts! Wise to be paying attention to this account, give him a proper follow 👍 $TOVX and $CHAI looks really good

1 · Reply

RealFValue Aug. 21 at 6:59 AM

$TOVX systematically fuck retail 🫶🏼😆

0 · Reply

OutLawTrades Aug. 21 at 12:02 AM

$TOVX A lot of people were saying $OCGN wasn’t going to bounce, and one day she did to $18.15 Are you guys ready for that? Because this place is for cancer medicine we’re talking about

0 · Reply

Lovelife68 Aug. 20 at 4:11 PM

$TOVX Theriva™ Biologics Receives Rare Pediatric Drug Designation by the U.S. FDA for VCN-01 for the Treatment of Retinoblastoma in July 2024! 2 years later still on phase 1. This is a high unmet need and has fast track but they move to other projects once on is successful.

0 · Reply

exwallstcfo Aug. 20 at 3:15 PM

$TOVX excellent .... well written .... wake up people https://newsweedcom.substack.com/p/tovx-theriva-biologics-stomach-ache?utm_campaign=post&utm_medium=web

1 · Reply